Chronic Lymphocytic Leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1447
|
291
|
0.030 |
None |
1.000 |
3 |
|
2018 |
2020 |
Adult T-Cell Lymphoma/Leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
540
|
11
|
0.310 |
None |
1.000 |
2 |
|
2012 |
2015 |
Precursor Cell Lymphoblastic Leukemia Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
879
|
168
|
0.310 |
None |
1.000 |
2 |
|
2002 |
2013 |
Lupus Erythematosus, Systemic
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
1883
|
1172
|
0.100 |
None |
1.000 |
2 |
2
|
2015 |
2016 |
Recurrent Chronic Lymphoid Leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
12
|
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |
Small Lymphocytic Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
120
|
122
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |
L2 Acute Lymphoblastic Leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
53
|
|
0.300 |
None |
1.000 |
1 |
|
2013 |
2013 |
Childhood Acute Lymphoblastic Leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1096
|
261
|
0.300 |
None |
1.000 |
1 |
|
2013 |
2013 |
Serum gamma-glutamyl transferase measurement
|
phenotype |
|
Laboratory Procedure
|
54
|
108
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Systemic Scleroderma
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
979
|
287
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Systolic Pressure
|
phenotype |
|
Clinical Attribute
|
843
|
1931
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Blood basophil count (lab test)
|
phenotype |
|
Laboratory Procedure
|
272
|
452
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
White Blood Cell Count procedure
|
phenotype |
|
Laboratory Procedure
|
681
|
1322
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Eosinophil count procedure
|
phenotype |
|
Laboratory Procedure
|
610
|
1144
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Eczema
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
863
|
368
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Hypodiploid B Acute Lymphoblastic Leukemia
|
disease |
|
Neoplastic Process
|
4
|
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Methylenetetrahydrofolate reductase deficiency
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
5
|
4
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATE REDUCTASE ACTIVITY
|
disease |
|
Disease or Syndrome
|
5
|
78
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Autoimmune thyroiditis
|
disease |
Immune System Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
161
|
76
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Undifferentiated leukemia
|
disease |
|
Neoplastic Process
|
120
|
2
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Eosinophilic disorder
|
group |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
288
|
22
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
42
|
14
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Hashimoto Disease
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
335
|
131
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Leukemogenesis
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
996
|
25
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |